Based on the above data, we hypothesized that reduction of PTRF may restore the impaired PI3K/Akt signaling pathway, and thus, reduce TLR4 activation and alleviate hepatic damage in NAFLD + CIA rats. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.